FDA Investigator Emily A Baldwin
Emily A Baldwin has inspections in 4 countries as of 15 Mar 2024. Emily A Baldwin has collaborated with a combined 821 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
15 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Czechia,
France,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Anabel Veiga,
Andrea H Norwood,
Andrew J Mcguffin,
Angela F Orozco,
Ann B Borromeo,
Brunidla Torres,
Brunilda Torres,
Chinyere A Asanya,
Christopher T Smith,
Clara E Santiago,
Craig A Garmendia,
Dawn M Mccabe,
Donna D Gallien, MPH,
Dr. Koffi A Amegadje,
Eduardo Carbonell,
Edwards,
Emily A Green,
Emily C Caldwell,
Emily S Baldwin,
Gene R Gunn,
Hugh M Mcclure, II,
James To Neal,
Jason P Aun,
Jonathan R Campos,
Jose Acruz Gonzalez,
Karissa J Mccaw,
Ladislav Kermet,
Latrice G Jones,
Laura L Staples,
LCDR Angelica M Chica,
LCDR Randall L Morris,
Lissette Paiz,
Lori A Gioia,
LT Richard A Lyght,
Matthew F Duff,
Omayra Nrodriguez Ruiz,
Pablo Alcantara,
Paul H Dakin,
Robert J Goldman,
Ruth A Williams,
Sally Gopaul,
Sharon Giamberini,
Stacey F Allard,
Stacey F Rivette,
Stacey L Witherwax,
State Agency,
Timothy A Tennell
Emily A Baldwin's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2023 | FDA 483 Response | Maria Cuesta Torres, M.D. - Form 483R, 2023-05-30 |
October, 2022 | FDA 483 | Humberto Hernandez, M.D. - Form 483, 2022-10-13 |
December, 2021 | FDA 483 | William E. Sanchez, M.D. - Form 483, 2021-12-22 |
July, 2022 | FDA 483 | Wilfrido A. Benitez, M.D. - Form 483, 2022-07-21 |
May, 2023 | FDA 483 | Maria Cuesta Torres, M.D. - Form 483, 2023-05-18 |
August, 2023 | FDA 483 | Nova Southeastern University IRB #1 - Form 483, 2023-08-17 |
September, 2023 | FDA 483 | Dr. Bruce G. Rankin, DO - Form 483, 2023-09-22 |
January, 2023 | FDA 483 | Luis Pena-Hernandez, M.D. - Form 483, 2023-01-23 |
June, 2023 | FDA 483 | Orlando L. Rivero, MD - Form 483, 2023-06-08 |
December, 2023 | FDA 483 | Dr. James A. Thompson, M.D. - Form 483, 2023-12-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more